
Why a 25-cent pill is being sold to cancer patients for nearly $1,000
Apple News In Conversation
00:00
Intro
This chapter explores the journey of a multiple myeloma patient from initial symptoms to diagnosis and treatment. It highlights the disparity between the low production cost of the drug Revlimid and its high retail price, questioning the ethics of pharmaceutical pricing for vital medications.
Transcript
Play full episode